HEALTHALLAFRICA
Africa: Twice-Yearly Lenacapavir Continues to Show Strong HIV Prevention Results
Twice-yearly injectable lenacapavir has continued to demonstrate exceptional protection against HIV infection. The drug shows strong HIV prevention results as reported by allAfrica.
Related Signal
Adjacent reporting
- Lenacapavir will slow HIV infections if there's enough of it and it reaches at-risk groups
- Africa: 'One Injection Protects Up to Six Months' - What Is New HIV Drug Lenacapavir?
- Highly effective prevention drug arrives in South Africa, which has world’s highest HIV burden
- Mass rollout planned across Southern Africa for new HIV drug
- South Africa: Gauteng Health Exceeds Lenacapavir Rollout Targets